Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 55976 - 56000 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Panobinostat	Approved Investigational	CDC42EP5	148170	upregulated	panobinostat results in increased expression of CDC42EP5 mRNA	19q13.42	A21037
Panobinostat	Approved Investigational	CDH1	999	upregulated	panobinostat results in increased expression of CDH1 mRNA	16q22.1	A21037
Panobinostat	Approved Investigational	CDH10	1008	upregulated	panobinostat results in increased expression of CDH10 mRNA	5p14.2-p14.1	A21037
Panobinostat	Approved Investigational	CDH18	1016	upregulated	panobinostat results in increased expression of CDH18 mRNA	5p14.3	A21037
Panobinostat	Approved Investigational	CDH2	1000	downregulated	panobinostat results in decreased expression of CDH2 mRNA	18q12.1	A21037
Panobinostat	Approved Investigational	CDH3	1001	upregulated	panobinostat results in increased expression of CDH3 mRNA	16q22.1	A21037
Panobinostat	Approved Investigational	CDH8	1006	downregulated	panobinostat results in decreased expression of CDH8 mRNA	16q21	A21037
Panobinostat	Approved Investigational	CDK6	1021	upregulated	panobinostat results in increased expression of CDK6 mRNA	7q21.2	A21037
Panobinostat	Approved Investigational	CDON	50937	upregulated	panobinostat results in increased expression of CDON mRNA	11q24.2	A21037
Panobinostat	Approved Investigational	CEBPB	1051	upregulated	panobinostat results in increased expression of CEBPB mRNA	20q13.13	A21037
Panobinostat	Approved Investigational	CEBPD	1052	upregulated	panobinostat results in increased expression of CEBPD mRNA	8q11.21	A21037
Panobinostat	Approved Investigational	CELF5	60680	downregulated	panobinostat results in decreased expression of CELF5 mRNA	19p13.3	A21037
Panobinostat	Approved Investigational	CEP85L	387119	upregulated	panobinostat results in increased expression of CEP85L mRNA	6q22.31	A21037
Panobinostat	Approved Investigational	CGNL1	84952	upregulated	panobinostat results in increased expression of CGNL1 mRNA	15q21.3	A21037
Panobinostat	Approved Investigational	CHAC1	79094	upregulated	panobinostat results in increased expression of CHAC1 mRNA	15q15.1	A21037
Panobinostat	Approved Investigational	CHGA	1113	upregulated	panobinostat results in increased expression of CHGA mRNA	14q32.12	A21037
Panobinostat	Approved Investigational	CHODL	140578	upregulated	panobinostat results in increased expression of CHODL mRNA	21q21.1	A21037
Panobinostat	Approved Investigational	CHRM3	1131	upregulated	panobinostat results in increased expression of CHRM3 mRNA	1q43	A21037
Panobinostat	Approved Investigational	CHST15	51363	upregulated	panobinostat results in increased expression of CHST15 mRNA	10q26.13	A21037
Panobinostat	Approved Investigational	CHST4	10164	upregulated	panobinostat results in increased expression of CHST4 mRNA	16q22.2	A21037
Panobinostat	Approved Investigational	CHSY1	22856	upregulated	panobinostat results in increased expression of CHSY1 mRNA	15q26.3	A21037
Panobinostat	Approved Investigational	CITED2	10370	upregulated	panobinostat results in increased expression of CITED2 mRNA	6q24.1	A21037
Panobinostat	Approved Investigational	CLDN1	9076	upregulated	panobinostat results in increased expression of CLDN1 mRNA	3q28	A21037
Panobinostat	Approved Investigational	CLDN23	137075	upregulated	panobinostat results in increased expression of CLDN23 mRNA	8p23.1	A21037
Panobinostat	Approved Investigational	CLDN4	1364	upregulated	panobinostat results in increased expression of CLDN4 mRNA	7q11.23	A21037

Displaying entries 55976 - 56000 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability